Legal Opinion

In re Abilify (Aripiprazole) Prods. Liab. Litig.

District Court, N.D. Florida

Decided March 15, 2018No. Case No. 3:16-md-2734PublishedCited by 20 opinions

1Opinion of the Court

M. CASEY RODGERS, CHIEF UNITED STATES DISTRICT JUDGE

This is a multidistrict product liability action against the manufacturers and marketers of the prescription drug Aripiprazole, more commonly known as Abilify.2 Plaintiffs allege that, after taking Abilify as prescribed, they developed impulsive and irrepressible urges to engage in certain harmful behaviors, including impulsive gambling, eating, shopping, and sex.3 Defendants *1301deny the allegations and maintain that Abilify could not, and did not, cause Plaintiffs' impulse control problems.

Defendants have moved for summary judgment on the…

2Cases cited69 opinions

  1. Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
  2. Kumho Tire Co. v. CarmichaelSupreme Court of the United States · 1999
  3. General Electric Co. v. JoinerSupreme Court of the United States · 1997
  4. Exxon Mobil Corp. v. Allapattah Services, Inc.Supreme Court of the United States · 2005
  5. In Re Paoli Railroad Yard PCB LitigationCourt of Appeals for the Third Circuit · 1994

64 more not listed; retrieve them via the Exa API.

3Cited by20 opinions

  1. In re Mirena Ius Levonorgestrel-Related Prods. Liab. Litig.District Court, S.D. Illinois · 2018
  2. In re Roundup Prods. Liab. Litig.District Court, N.D. California · 2018
  3. Bishara v. Secretary of Health and Human ServicesUnited States Court of Federal Claims · 2023
  4. Bulow v. United StatesDistrict Court, M.D. Florida · 2021
  5. CULLIVER v. BP EXPLORATION AND PRODUCTION INCDistrict Court, N.D. Florida · 2024

15 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API